Unknown

Dataset Information

0

Regulating mammalian target of rapamycin to tune vaccination-induced CD8(+) T cell responses for tumor immunity.


ABSTRACT: Vaccine strategies aimed at generating CD8(+) T cell memory responses are likely to show augmented efficacy against chronic challenges like tumor. The abundance in variety of memory CD8(+) T cells behooves development of vaccine strategies that generate distinct memory responses and evaluate them for tumor efficacy. In this study, we demonstrate the ability of a variety of rapamycin treatment regimens to regulate virus vaccination-induced CD8(+) T cell memory responses and tumor efficacy. Strikingly, a short course of high-dose, but not low-dose, rapamycin treatment transiently blocks viral vaccination-induced mammalian target of rapamycin activity in CD8(+) T cells favoring persistence and Ag-recall responses over type 1 effector maturation; however, prolonged high-dose rapamycin administration abrogated memory responses. Furthermore, a short course of high-dose rapamycin treatment generated CD8(+) T cell memory responses that were independent of IL-15 and IL-7 and were programmed early for sustenance and greater tumor efficacy. These results demonstrate the impact a regimen of rapamycin treatment has on vaccine-induced CD8(+) T cell responses and indicates that judicious application of rapamycin can augment vaccine efficacy for chronic challenges.

SUBMITTER: Li Q 

PROVIDER: S-EPMC3311730 | biostudies-literature | 2012 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Regulating mammalian target of rapamycin to tune vaccination-induced CD8(+) T cell responses for tumor immunity.

Li Qingsheng Q   Rao Rajesh R   Vazzana Joseph J   Goedegebuure Peter P   Odunsi Kunle K   Gillanders William W   Shrikant Protul A PA  

Journal of immunology (Baltimore, Md. : 1950) 20120229 7


Vaccine strategies aimed at generating CD8(+) T cell memory responses are likely to show augmented efficacy against chronic challenges like tumor. The abundance in variety of memory CD8(+) T cells behooves development of vaccine strategies that generate distinct memory responses and evaluate them for tumor efficacy. In this study, we demonstrate the ability of a variety of rapamycin treatment regimens to regulate virus vaccination-induced CD8(+) T cell memory responses and tumor efficacy. Striki  ...[more]

Similar Datasets

| S-EPMC3407681 | biostudies-literature
| S-EPMC6412382 | biostudies-literature
| S-EPMC3871936 | biostudies-literature
| S-EPMC7000514 | biostudies-literature
| S-EPMC3378878 | biostudies-literature
| S-EPMC3773272 | biostudies-literature
| S-EPMC2821410 | biostudies-literature
| S-EPMC135667 | biostudies-literature
| S-EPMC3814157 | biostudies-literature
| S-EPMC5815439 | biostudies-literature